Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Anais brasileiros de dermatologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100137 |
Resumo: | Abstract The use of tumor necrosis factor antagonists (anti-TNF) has become a usual practice to treat various inflammatory diseases. Although indicated for the treatment of psoriasis, anti-TNF may paradoxically trigger a psoriasiform condition. We present a case of a female patient who, during the use of infliximab for rheumatoid arthritis, developed psoriasis. In an attempt to switch anti-TNF class, we observed a cumulative worsening of the lesions requiring suspension of the immunobiological agent and the introduction of other drugs for clinical control. The therapeutic challenge of this paradoxical form of psoriasis is the focus of our discussion. The use of another anti-TNF in these patients is a matter of debate among experts. |
id |
SBD-1_994666e7de49550834cf734acaed1bc7 |
---|---|
oai_identifier_str |
oai:scielo:S0365-05962016001100137 |
network_acronym_str |
SBD-1 |
network_name_str |
Anais brasileiros de dermatologia (Online) |
repository_id_str |
|
spelling |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritisInterferonsPsoriasisTherapeuticsTumor necrosis factor-alphaAbstract The use of tumor necrosis factor antagonists (anti-TNF) has become a usual practice to treat various inflammatory diseases. Although indicated for the treatment of psoriasis, anti-TNF may paradoxically trigger a psoriasiform condition. We present a case of a female patient who, during the use of infliximab for rheumatoid arthritis, developed psoriasis. In an attempt to switch anti-TNF class, we observed a cumulative worsening of the lesions requiring suspension of the immunobiological agent and the introduction of other drugs for clinical control. The therapeutic challenge of this paradoxical form of psoriasis is the focus of our discussion. The use of another anti-TNF in these patients is a matter of debate among experts.Sociedade Brasileira de Dermatologia2016-10-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100137Anais Brasileiros de Dermatologia v.91 n.5 suppl.1 2016reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20164456info:eu-repo/semantics/openAccessVasconcellos,Jaqueline Barbeito dePereira,Daniele do NascimentoVargas,Thiago Jeunon de SousaLevy,Roger AbraminoPinheiro,Geraldo da Rocha CastelarCursi,Ígor Brumeng2017-03-03T00:00:00Zoai:scielo:S0365-05962016001100137Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2017-03-03T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false |
dc.title.none.fl_str_mv |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
title |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
spellingShingle |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis Vasconcellos,Jaqueline Barbeito de Interferons Psoriasis Therapeutics Tumor necrosis factor-alpha |
title_short |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
title_full |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
title_fullStr |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
title_full_unstemmed |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
title_sort |
Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis |
author |
Vasconcellos,Jaqueline Barbeito de |
author_facet |
Vasconcellos,Jaqueline Barbeito de Pereira,Daniele do Nascimento Vargas,Thiago Jeunon de Sousa Levy,Roger Abramino Pinheiro,Geraldo da Rocha Castelar Cursi,Ígor Brum |
author_role |
author |
author2 |
Pereira,Daniele do Nascimento Vargas,Thiago Jeunon de Sousa Levy,Roger Abramino Pinheiro,Geraldo da Rocha Castelar Cursi,Ígor Brum |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Vasconcellos,Jaqueline Barbeito de Pereira,Daniele do Nascimento Vargas,Thiago Jeunon de Sousa Levy,Roger Abramino Pinheiro,Geraldo da Rocha Castelar Cursi,Ígor Brum |
dc.subject.por.fl_str_mv |
Interferons Psoriasis Therapeutics Tumor necrosis factor-alpha |
topic |
Interferons Psoriasis Therapeutics Tumor necrosis factor-alpha |
description |
Abstract The use of tumor necrosis factor antagonists (anti-TNF) has become a usual practice to treat various inflammatory diseases. Although indicated for the treatment of psoriasis, anti-TNF may paradoxically trigger a psoriasiform condition. We present a case of a female patient who, during the use of infliximab for rheumatoid arthritis, developed psoriasis. In an attempt to switch anti-TNF class, we observed a cumulative worsening of the lesions requiring suspension of the immunobiological agent and the introduction of other drugs for clinical control. The therapeutic challenge of this paradoxical form of psoriasis is the focus of our discussion. The use of another anti-TNF in these patients is a matter of debate among experts. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100137 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100137 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/abd1806-4841.20164456 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Dermatologia |
dc.source.none.fl_str_mv |
Anais Brasileiros de Dermatologia v.91 n.5 suppl.1 2016 reponame:Anais brasileiros de dermatologia (Online) instname:Sociedade Brasileira de Dermatologia (SBD) instacron:SBD |
instname_str |
Sociedade Brasileira de Dermatologia (SBD) |
instacron_str |
SBD |
institution |
SBD |
reponame_str |
Anais brasileiros de dermatologia (Online) |
collection |
Anais brasileiros de dermatologia (Online) |
repository.name.fl_str_mv |
Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD) |
repository.mail.fl_str_mv |
abd@sbd.org.br||revista@sbd.org.br |
_version_ |
1752126421738717184 |